Clinical Trials Browser

Phase 4 × Pancreatic Cancer Non-resectable × 90 days × Clear all

NCT07302841 2025-12-24

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Phase 4 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Non-resectable